Business Description
Lobe Sciences Ltd
NAICS : 541714
SIC : 3741
ISIN : CA53946V2066
Compare
Compare
Traded in other countries / regions
LOBE.CanadaLOBEF.USA6YX0.Germany IPO Date
2019-10-01Description
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -0.59 | |||||
| Debt-to-Equity | -0.3 | |||||
| Debt-to-EBITDA | -0.35 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -28.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year EPS without NRI Growth Rate | 41.6 | |||||
| 3-Year FCF Growth Rate | 45.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.09 | |||||
| 9-Day RSI | 48.4 | |||||
| 14-Day RSI | 49.29 | |||||
| 6-1 Month Momentum % | -9.7 | |||||
| 12-1 Month Momentum % | -43.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.05 | |||||
| Days Inventory | 2859.17 | |||||
| Days Sales Outstanding | 17.44 | |||||
| Days Payable | 425955 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.1 | |||||
| Shareholder Yield % | -4.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.53 | |||||
| Operating Margin % | -835.29 | |||||
| Net Margin % | -855.15 | |||||
| FCF Margin % | -92.93 | |||||
| ROA % | -59.87 | |||||
| ROIC % | -57.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.53 | |||||
| EV-to-EBIT | -3.26 | |||||
| EV-to-EBITDA | -3.42 | |||||
| EV-to-Revenue | 27.03 | |||||
| EV-to-FCF | -29.02 | |||||
| Earnings Yield (Greenblatt) % | -30.67 | |||||
| FCF Yield % | -3.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LOBEF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lobe Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.099 | ||
| EPS (TTM) ($) | -0.014 | ||
| Beta | -0.08 | ||
| Volatility % | 68.76 | ||
| 14-Day RSI | 49.29 | ||
| 14-Day ATR ($) | 0.002332 | ||
| 20-Day SMA ($) | 0.015313 | ||
| 12-1 Month Momentum % | -43.98 | ||
| 52-Week Range ($) | 0.01 - 0.0299 | ||
| Shares Outstanding (Mil) | 164.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lobe Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lobe Sciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lobe Sciences Ltd Frequently Asked Questions
What is Lobe Sciences Ltd(LOBEF)'s stock price today?
The current price of LOBEF is $0.01. The 52 week high of LOBEF is $0.03 and 52 week low is $0.01.
When is next earnings date of Lobe Sciences Ltd(LOBEF)?
The next earnings date of Lobe Sciences Ltd(LOBEF) is 2024-07-31 Est..
Does Lobe Sciences Ltd(LOBEF) pay dividends? If so, how much?
Lobe Sciences Ltd(LOBEF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers